Clinical Research Directory
Browse clinical research sites, groups, and studies.
Necessity of TSH Suppression Therapy in Active Surveillance for Thyroid Cancer Patients.
Sponsor: National Cancer Center, Korea
Summary
This study is a multicenter randomized controlled trial conducted in Korea. A parallel, two-group randomized design will be with thyroid stimulating hormone suppression therapy group(low TSH group; intervention) is different from the wIthout thyroid stimulating hormone (TSH) suppression therapy group(high TSH group; control).
Key Details
Gender
All
Age Range
19 Years - 79 Years
Study Type
INTERVENTIONAL
Enrollment
578
Start Date
2025-06-02
Completion Date
2032-12-31
Last Updated
2025-05-14
Healthy Volunteers
No
Interventions
Levothyroxin
During the five-year study intervention period, thyroid hormone (oral administration) supplementary doses are determined according to a dose-adjustment protocol established for the group's target TSH range.